Neuphoria Therapeutics In... (NEUP)
NASDAQ: NEUP
· Real-Time Price · USD
11.89
-0.03 (-0.25%)
At close: Sep 05, 2025, 3:59 PM
12.14
2.10%
After-hours: Sep 05, 2025, 06:59 PM EDT
-0.25% (1D)
| Bid | 11.25 |
| Market Cap | 22.35M |
| Revenue (ttm) | 15.66M |
| Net Income (ttm) | 5.74M |
| EPS (ttm) | 17.28 |
| PE Ratio (ttm) | 0.69 |
| Forward PE | -6.27 |
| Analyst | Buy |
| Ask | 12.5 |
| Volume | 40,402 |
| Avg. Volume (20D) | 44,653 |
| Open | 12.25 |
| Previous Close | 11.92 |
| Day's Range | 11.35 - 12.62 |
| 52-Week Range | 2.12 - 13.34 |
| Beta | 0.58 |
About NEUP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NEUP
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NEUP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
Neuphoria Therapeutics shares are trading higher a...
Unlock content with
Pro Subscription
3 months ago · https://www.marketscreener.com
Neuphoria to Present at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual MeetingBURLINGTON, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“Neuphoria” or the “Company”), a clinical-stage biotechnology company developing impactful treatments fo...